You should discuss cannabis use before starting GLP-1 medications
We have seen good coverage for hospital employees (Health One, Childrens), technology companies (Lockhead Martin, Aerospace), oil and gas companies, financials (Fidelity) and others
The conflicting data in some clinical studies may be explained by various factors: [1] most cohort studies lacked individual validation of fractures as primary outcomes, [2] the studies had short follow-up duration and [3] did not consider important risk factors for osteoporosis such as BMD (even though BMD is not a good method for diagnosing osteoporosis in T2DM), and [4] some studies included medications that affect fracture risk, such as corticosteroids or antidepressants
Sorry, they ate more
Mild symptoms such as nausea or fatigue may occur at first
The main published Phase 2 obesity study looked at retatrutide in adults with obesity, or overweight with at least one weight-related condition